Antibodies to microbiome, stress factors and mast cell markers as diagnostic markers for IBS
US10184940B2 · kind B2 · utility
1Cited by
1References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 30, 2015 |
| Grant date | Jan 22, 2019 |
| Priority date | — |
| Expiry date | May 14, 2037 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/60
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present invention provides methods for aiding in the diagnosis of irritable bowel syndrome (IBS) in an individual. In particular, the present invention is useful for determining whether a sample from an individual is an IBS sample or a healthy control sample using a statistical algorithm. Thus, the present invention provides an accurate diagnostic prediction of IBS and is useful for guiding treatment decisions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.